Meitheal Pharmaceuticals has Pemetrexed for Injection, USP Now Available.

Meitheal Pharmaceuticals (Meitheal) is pleased to announce we have launched Pemetrexed for Injection, USP in 100 mg per 10 mL vial in a single-dose vial and 500 mg per 50 mL vial in a single-dose vial.

Meitheal will offer Pemetrexed for Injection, USP in carton of 1 vial for both presentations.


Pemetrexed for Injection, USP is indicated in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations. For full prescribing information, and safety information, including boxed warning, please click on the following link.     


Learn more about who we are and what we do at